Ovid Therapeutics
OVID
#7730
Rank
โ‚น38.47 B
Marketcap
โ‚น203.85
Share price
-5.98%
Change (1 day)
62.52%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2026 (TTM): -โ‚น28.53

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น28.72. In 2025 the company made an earnings per share (EPS) of -โ‚น28.72 an increase over its 2024 EPS that were of -โ‚น35.21.

EPS history for Ovid Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น28.53-0.68%
2025-โ‚น28.72-18.42%
2024-โ‚น35.21
2022-โ‚น71.35-143.5%
2021โ‚น164.01-226.43%
2020-โ‚น129.72-11.39%
2019-โ‚น146.40-25.47%
2018-โ‚น196.44-24.06%
2017-โ‚น258.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09 335.48%๐Ÿ‡บ๐Ÿ‡ธ USA